Voloridge Investment Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
VPM
VCM
B
Voloridge Investment Management's NEO Position: Q1 2026 in Review
Voloridge Investment Management reduced its NeoGenomics (NEO) stake by 54% in Q1 2026, selling an estimated $3.35M and leaving 275,771 shares worth $2.05M. The position accounts for 0.01% of the portfolio, ranked #826.
Voloridge Investment Management first reported a position in NEO in Q1 2019 and has held it in 21 quarters since. The position peaked at $9.53M in Q3 2025. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.
- Voloridge Investment Management held 275,771 shares of NeoGenomics worth $2.05M as of Q1 2026.
- Voloridge Investment Management sold 318,019 NeoGenomics shares in Q1 2026, an estimated $3.35M.
- NeoGenomics made up 0.01% of Voloridge Investment Management's portfolio in Q1 2026, its #826 holding.
- Voloridge Investment Management first reported a position in NeoGenomics in Q1 2019 and has held it in 21 quarters since.
- Voloridge Investment Management's NeoGenomics position peaked at $9.53M in Q3 2025.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.
Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.